Insiders Go Shopping: H&M, Pfizer, Aptiv
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
The biggest insider story this week is H&M's controlling family loading up on stock. Stefan Persson — a close relative of the founding Persson family — filed on August 17 that he bought 3.1 million HM B shares across three days. The total tab: $56.8 million. Persson paid roughly SEK 175 per share. That is a bold, concentrated bet on the Swedish fashion giant.
Across the Atlantic, APTV saw a rare coordinated buy. Three insiders filed purchases totalling over $8 million. Chairman and CEO Kevin Clark spent $2.5M on August 10. Director Paul Meister went even bigger — filing a $5M buy on August 6. The stock has been under pressure this year. These filings suggest confidence at the top.
PFE also drew attention. CEO Albert Bourla filed a $1M purchase on August 12, paying $26.34 per share. Two other directors bought near the same price days earlier. Three insiders buying Pfizer within days of each other stands out for a large-cap pharma name.
On the sell side, CVE CEO Jonathan McKenzie filed two large sales totalling over $12.3 million in recent weeks, offloading shares between $42–$43. The Cenovus Energy chief trimmed his position while oil prices remain volatile.
This article is for informational purposes only and does not constitute financial advice.
Stocks in this article
How this article was generated
- Generated
- 18 Aug 2026, 04:12
- Prompt version
- v1.0
- Data sources
- Institutional positioning
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.